BSEBoard Meeting2d ago · 5 Aug 2026, 11:34 am
Titan Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve the standalone and consolidated ....
Titan Biotech Ltd · 524717
✦ AI SummaryResults
Titan Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 to consider and approve the standalone and consolidated unaudited financial results for the quarter ended June 30, 2026.
Analysis Scores
Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Titan Biotech Ltd - 524717 - Board Meeting Intimation for Consideration And Approval Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended June 30, 2026.